Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake

Molecular Biology of the Cell

Volumn 13, Issue 7, 2002, Pages 2276-2288

  Edinger, Aimee L ^a   Thompson, Craig B ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN KINASE; PROTEIN KINASE B; UNCLASSIFIED DRUG; AMINO ACID; BCL2L1 PROTEIN, MOUSE; CD98 ANTIGEN; CHOLESTEROL; ENZYME INHIBITOR; GLUCOSE; GLUCOSE TRANSPORTER; GLUCOSE TRANSPORTER 1; GROWTH PROMOTOR; HYBRID PROTEIN; INTERLEUKIN 3; IRON; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; ONCOPROTEIN; PROTEIN BCL 2; PROTEIN BCL X; PROTEIN KINASE INHIBITOR; PROTEIN SERINE THREONINE KINASE; RAPAMYCIN;

ANIMAL CELL; ARTICLE; CELL MEMBRANE TRANSPORT; CELL SIZE; CELL SURVIVAL; CONTROLLED STUDY; GLUCOSE METABOLISM; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ANIMAL; CELL LINE; CELL MEMBRANE POTENTIAL; DRUG EFFECT; ENZYME ACTIVATION; GENETICS; METABOLISM; MITOCHONDRION; MOUSE; PHYSIOLOGY; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALIA;

AMINO ACIDS; ANIMALS; ANTIGENS, CD98 HEAVY CHAIN; BCL-X PROTEIN; BIOLOGICAL TRANSPORT; CELL LINE; CELL SIZE; CELL SURVIVAL; CHOLESTEROL; ENZYME ACTIVATION; ENZYME INHIBITORS; GLUCOSE; GLUCOSE TRANSPORTER TYPE 1; GROWTH SUBSTANCES; INTERLEUKIN-3; IRON; LIPOPROTEINS, LDL; MEMBRANE POTENTIALS; MICE; MITOCHONDRIA; MONOSACCHARIDE TRANSPORT PROTEINS; PROTEIN KINASE INHIBITORS; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, LDL; RECOMBINANT FUSION PROTEINS; SIROLIMUS;

EID: 0036320205     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.01-12-0584     Document Type: Article

References (50)

1. Chemistry and biology of eukaryotic iron metabolism
2. The akt kinase: Molecular determinants of oncogenicity
3. A role of the kinase mTOR in cellular transformation induced by the oncoproteins P3k and Akt
4. Starvation induces vacuolar targeting and degradation of the tryptophan permease in yeast
5. Metabolic changes in activated T cells: An NMR study of human peripheral blood lymphocytes
6. Oncogenic kinase signaling
7. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo
8. Metabolic alterations associated with proliferation of mitogen-activated lymphocytes and of lymphoblastoid cell lines: Evaluation of glucose and glutamine metabolism
9. Manipulations of cellular iron metabolism for modulating normal and malignant cell proliferation: Achievements and prospects
10. Size control in animal development
11. Cellular survival: A play in three Akts
12. Surface antigen CD98(4F2): Not a single membrane protein, but a family of proteins with multiple functions
13. Endocytosis and mitogenic signaling
14. Differential sensitivity of various pediatric cancers and squamous cell carcinomas to lovastatin-induced apoptosis: Therapeutic implications
15. Endocytosis proteins and cancer: A potential link?
16. Energy metabolism during apoptosis. Bcl-2 promotes survival in hematopoietic cells induced to apoptose by growth factor withdrawal by stabilizing a form of metabolic arrest
17. Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase
18. Malignant transformation of NIH3T3 cells by overexpression of early lymphocyte activation antigen CD98
19. Enhanced tumorigenicity caused by truncation of the extracellular domain of GP125/CD98 heavy chain
20. The rapamycin-sensitive signal transduction pathway as a target for cancer therapy
21. Amino acid-dependent control of p70(s6k). Involvement of tRNA aminoacylation in the regulation
22. Apoptosis is regulated by the rate of glucose transport in an interleukin 3 dependent cell line
23. The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB
24. Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression
25. Tumor induction by an Lck-MyrAkt transgene is delayed by mechanisms controlling the size of the thymus
26. Mitochondria-dependent apoptosis and cellular pH regulation
27. Glutamine and cancer
28. Linking molecular therapeutics to molecular diagnostics: Inhibition of the FRAP/RAFT/TOR component of the PI3K pathway preferentially blocks PTEN mutant cells in vitro and in vivo
29. Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR
30. Iron-dependent changes in cellular energy metabolism: Influence on citric acid cycle and oxidative phosphorylation
31. Molecular biology of mammalian plasma membrane amino acid transporters
32. Akt, and Bcl-xL promote growth factor-independent survival through distinct effects on mitochondrial physiology
33. Cell metabolism in the regulation of programmed cell death
34. An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten+/- mice
35. Social controls on cell survival and death
36. Size control: The regulation of cell numbers in animal development
37. In the absence of extrinsic signals, nutrient utilization by lymphocytes is insufficient to maintain either cell size or viability
38. The target of rapamycin (TOR) proteins
39. TOR, a central controller of cell growth
40. The TOR nutrient signaling pathway phosphorylates NPR1 and inhibits turnover of the tryptophan permease
41. Evidence of insulin-stimulated phosphorylation and activation of the mammalian target of rapamycin mediated by a protein kinase B signaling pathway
42. A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells
43. How cells handle cholesterol
44. Iron in cancer
45. Growth factor signaling in cell survival: Implications for cancer treatment
46. AKT plays a central role in tumorigenesis
47. L prevents cell death following growth factor withdrawal by facilitating mitochondrial ATP/ADP exchange
48. Growth factors can influence cell growth and survival through effects on glucose metabolism
49. Hemopoietic cell growth factor mediates cell survival via its action on glucose transport